Patents by Inventor Matthew Cooper
Matthew Cooper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20210122739Abstract: The present invention relates to sulfonylureas and sulfonylthioureas comprising a 5-membered heteroaryl group substituted with an amide-containing group. The present invention further relates to salts, solvates and prodrugs of such compounds, to pharmaceutical compositions comprising such compounds, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by the inhibition of NLRP3.Type: ApplicationFiled: August 15, 2018Publication date: April 29, 2021Applicant: Inflazome LimitedInventors: Matthew COOPER, David MILLER, Angus MACLEOD, Stephen THOM, Stephen ST-GALLAY, Jonathan SHANNON
-
Patent number: 10978079Abstract: A method for encoding an input audio stream including the steps of obtaining a first playback stream presentation of the input audio stream intended for reproduction on a first audio reproduction system, obtaining a second playback stream presentation of the input audio stream intended for reproduction on a second audio reproduction system, determining a set of transform parameters suitable for transforming an intermediate playback stream presentation to an approximation of the second playback stream presentation, wherein the transform parameters are determined by minimization of a measure of a difference between the approximation of the second playback stream presentation and the second playback stream presentation, and encoding the first playback stream presentation and the set of transform parameters for transmission to a decoder.Type: GrantFiled: August 24, 2016Date of Patent: April 13, 2021Assignees: Dolby Laboratories Licensing Corporation, Dolby International ABInventors: Dirk Jeroen Breebaart, David Matthew Cooper, Leif Jonas Samuelsson, Jeroen Koppens, Rhonda Joy Wilson, Heiko Purnhagen, Alexander Stahlmann
-
Patent number: 10947271Abstract: The invention concerns agents with antibacterial activity, their production and use in the treatment of bacterial infections in animals, including man. The agents are derivatives of vancomycin-type antibiotics, of structure X—W-L-V, wherein X is hydrogen, acetyl or a lipophilic membrane-insertive element, W is a basic peptide or basic amino acid; L is a linking group and V is a glycopeptide moiety which inhibits peptidoglycan biosynthesis in bacteria.Type: GrantFiled: February 10, 2015Date of Patent: March 16, 2021Assignee: THE UNIVERSITY OF QUEENSLANDInventors: Matthew Cooper, Mark Blaskovich
-
Patent number: 10932082Abstract: A system and method of modifying a binaural signal using headtracking information. The system calculates a delay, a first filter response, and a second filter response, and applies these to the left and right components of the binaural signal according to the headtracking information. The system may also apply headtracking to parametric binaural signals. In this manner, headtracking may be applied to pre-rendered binaural audio.Type: GrantFiled: June 20, 2017Date of Patent: February 23, 2021Assignee: Dolby Laboratories Licensing CorporationInventors: C. Phillip Brown, Joshua Brandon Lando, Mark F. Davis, Alan J. Seefeldt, David Matthew Cooper, Dirk Jeroen Breebaart, Rhonda Wilson
-
Publication number: 20210047302Abstract: The present invention relates to compounds of formula (I), wherein Q is selected from O or S; R1 is a 5- or 6-membered heteroaryl group consisting of one or more carbon atoms, and one or more nitrogen and/or oxygen atoms, and substituted with a monovalent, optionally substituted cycloalkyl, cycloalkenyl or heterocyclic group, wherein the 5- or 6-membered heteroaryl group of R1 may optionally be further substituted; R2 is an ?,??-substituted cyclic group which may optionally be further substituted; R3 and R4 are each independently hydrogen, halogen, —OH, —NH2, —CN, —R5, —OR5, —NHR5 or —N(R5)2; or R3 and R4 together with the carbon atom to which they are attached may form a 3- to 7-membered saturated or unsaturated, optionally substituted cyclic group; and R5 is independently an optionally substituted C1-C4 alkyl group.Type: ApplicationFiled: March 1, 2019Publication date: February 18, 2021Applicant: Inflazome LimitedInventors: Matthew COOPER, David MILLER, Jimmy VAN WILTENBURG
-
Publication number: 20210040065Abstract: The present invention relates to compounds of formula (I): comprising a 5-membered nitrogen-containing heteroaryl ring A, wherein the heteroaryl ring A is substituted with at least one group containing an oxygen atom, and wherein said oxygen atom is attached to the heteroaryl ring A via at least two other atoms. The present invention further relates to salts, solvates and prodrugs of such compounds, to pharmaceutical compositions comprising such compounds, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by the inhibition of NLRP3.Type: ApplicationFiled: March 1, 2019Publication date: February 11, 2021Inventors: David MILLER, Jimmy VAN WILTENBURG, Matthew COOPER
-
Patent number: 10913066Abstract: A microfluidic diagnostic chip may comprise a microfluidic channel, a functionalizable enzymatic sensor in the microfluidic channel, the functionalizable enzymatic sensor comprising a binding surface to bind with a biomarker in a fluid, and a microfluidic pump to pass the fluid over the binding surface. A microfluidic device may comprise a number of pumps to pump a fluid though the number of microfluidic channels and a number of microfluidic channels comprising at least one sensor to detect a change in a chemical characteristic of the fluid in response to presence of the fluid on the sensor.Type: GrantFiled: January 30, 2015Date of Patent: February 9, 2021Assignee: Hewlett-Packard Development Company, L.P.Inventors: Manish Giri, Chantelle Elizabeth Domingue, Nicholas Matthew Cooper McGuinness, Jeremy Sells, Sirena Lu, Melinda M. Valencia
-
Patent number: 10893375Abstract: A method of encoding channel or object based input audio for playback, the method including the steps of: (a) initially rendering the channel or object based input audio into an initial output presentation; (b) determining an estimate of the dominant audio component from the channel or object based input audio and determining a series of dominant audio component weighting factors for mapping the initial output presentation into the dominant audio component; (c) determining an estimate of the dominant audio component direction or position; and (d) encoding the initial output presentation, the dominant audio component weighting factors, the dominant audio component direction or position as the encoded signal for playback.Type: GrantFiled: July 18, 2019Date of Patent: January 12, 2021Assignees: Dolby Laboratories Licensing Corporation, Dolby International ABInventors: Dirk Jeroen Breebaart, David Matthew Cooper, Mark F. Davis, David S. McGrath, Kristofer Kjoerling, Harald Mundt, Rhonda J. Wilson
-
Publication number: 20210002274Abstract: The present invention relates to compounds of formula (I) wherein Q is selected from O or S; R1 is a saturated or unsaturated, optionally substituted hydrocarbyl group optionally including one or more heteroatoms N, O or S; R2 is a cyclic group substituted at the a and a? positions, wherein the substituent at the ?-position is a monovalent heterocyclic group or a monovalent aromatic group, wherein the heterocyclic or aromatic group may optionally be substituted, and wherein the cyclic group may optionally be further substituted; R3 and R4 are each independently hydrogen, halogen, —OH, —NH2, —CN, —R5, —OR5, —NHR5 or —N(R5)2; or R3 and R4 together with the carbon atom to which they are attached may form a 3- to 7-membered saturated or unsaturated, optionally substituted cyclic group; and R5 is independently optionally substituted C1-C4 alkyl.Type: ApplicationFiled: March 1, 2019Publication date: January 7, 2021Inventors: Matthew COOPER, David MILLER, Jimmy VAN WILTENBURG, Johannes Wilhem Georg MEISSNER, Jochem Theodoor VAN HERPT, Zhou Min LION, Jonathan SHANNON, Stephen ST-GALLAY
-
Publication number: 20200407340Abstract: The present invention relates to compounds of formula (I): (I) wherein Q is selected from O or S; R1 is an optionally substituted hydrocarbyl group which may optionally include one or more heteroatoms N, O or S in its carbon skeleton, provided that the hydrocarbyl group includes at least one heteroatom N, O or S in its carbon skeleton or is substituted with a substituent comprising at least one heteroatom N, O or S, and provided that the atom of R1 which is attached to the sulfur atom of the remainder of the molecule is not a ring atom of a cyclic group; R2 is an ?,??-substituted cyclic group which may optionally be further substituted; R3 and R4 are each independently hydrogen, halogen, —OH, —NH2, —CN, —R5, —OR5, —NHRs or —N(R5)2; or R3 and R4 together with the carbon atom to which they are attached may form a 3- to 7-membered saturated or unsaturated, optionally substituted cyclic group; and R5 is independently optionally substituted C1-C4 alkyl.Type: ApplicationFiled: March 1, 2019Publication date: December 31, 2020Inventors: Matthew COOPER, David MILLER, Jimmy VAN WILTENBURG, Jonathan SHANNON, Stephen ST-GALLAY
-
Publication number: 20200399243Abstract: The present invention relates to compounds of formula (1): wherein Q is selected from O or S; R1 is a 5-membered nitrogen-containing heteroaryl group substituted with R6 and optionally further substituted; R2 is an alpha, alpha?-substituted cyclic group which may optionally be further substituted; R3 and R4 are each independently hydrogen, halogen, —OH, —NH2, —CN, —R5, —OR5, —NHR5 or —N(R5)2; or R3 and R4 together with the carbon atom to which they are attached may form a 3 to 7 membered saturated or unsaturated, optionally substituted cyclic group; R5 is independently an optionally substituted C1-C4 alkyl group; and R6 is any group comprising a nitrogen atom. The present invention further relates to salts, solvates and prodrugs of such compounds, to pharmaceutical compositions comprising such compounds, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by the inhibition of NLRP3.Type: ApplicationFiled: March 1, 2019Publication date: December 24, 2020Inventors: David MILLER, Jimmy VAN WILTENBURG, Matthew COOPER
-
Publication number: 20200399242Abstract: The present invention relates to compounds of formula (I): wherein Q is selected from O or S; R1 is a non-aromatic heterocyclic group comprising at least one ring nitrogen atom, wherein R1 may optionally be substituted; R2 is an ?,??-substituted cyclic group which may optionally be further substituted; R3 and R4 are each independently hydrogen, halogen, —OH, —NH2, —CN, —R5, —OR5, —NHRs or —N(R5)2; or R3 and R4 together with the carbon atom to which they are attached may form a 3- to 7-membered saturated or unsaturated, optionally substituted cyclic group; and R5 is independently optionally substituted C1-C4 alkyl. The present invention further relates to salts, solvates and prodrugs of such compounds, to pharmaceutical compositions comprising such compounds, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by the inhibition of NLRP3.Type: ApplicationFiled: March 1, 2019Publication date: December 24, 2020Inventors: David MILLER, Jimmy VAN WILTENBURG, Matthew COOPER
-
Publication number: 20200361895Abstract: The present invention relates to compounds of formula (I): wherein Q is selected from O or S; R1 is a saturated or unsaturated, optionally substituted hydrocarbyl group optionally including one or more heteroatoms N, O or S; and R2 is a cyclic group substituted at the ?-position with a monovalent heterocyclic group or a monovalent aromatic group, wherein a ring atom of the heterocyclic or aromatic group is directly attached to the ? ring atom of the cyclic group, wherein the heterocyclic or aromatic group may optionally be substituted, and wherein the cyclic group may optionally be further substituted. The present invention further relates to salts, solvates and prodrugs of such compounds, to pharmaceutical compositions comprising such compounds, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by the inhibition of NLRP3.Type: ApplicationFiled: August 15, 2018Publication date: November 19, 2020Applicant: Inflazome LimitedInventors: Matthew COOPER, David MILLER, Angus MACLEOD, Jimmy VAN WILTENBURG, Stephen THOM, Stephen ST-GALLAY, Jonathan SHANNON, Thomas ALANINE, Stuart ONIONS, Ian STRUTT
-
Publication number: 20200361994Abstract: There is provided a range of novel compounds. These novel compounds may demonstrate abroad spectrum antibacterial and antifungal activity. These compounds may be active against the emerging polymyxin resistant bacteria. These compounds may also be useful when used in conjunction with other pharmaceutically active agents.Type: ApplicationFiled: November 2, 2018Publication date: November 19, 2020Inventors: Matthew COOPER, Mark BKASKOVICH, Alejandra GALLARDEO-GODLY, Karl HANSFORD, Slysha ELLOTT, Craig MULDOON, Bemd BECKER
-
Publication number: 20200357420Abstract: A method for representing a second presentation of audio channels or objects as a data stream, the method comprising the steps of: (a) providing a set of base signals, the base signals representing a first presentation of the audio channels or objects; (b) providing a set of transformation parameters, the transformation parameters intended to transform the first presentation into the second presentation; the transformation parameters further being specified for at least two frequency bands and including a set of multi-tap convolution matrix parameters for at least one of the frequency bands.Type: ApplicationFiled: May 26, 2020Publication date: November 12, 2020Applicant: DOLBY LABORATORIES LICENSING CORPORATIONInventors: Dirk Jeroen BREEBAART, David Matthew COOPER, Leif Jonas SAMUELSSON
-
Publication number: 20200354341Abstract: The present invention relates to sulfonylureas and sulfonylthioureas comprising a 5-membered heteroaryl group substituted with a monovalent heteroaryl-containing group. The present invention further relates to salts, solvates and prodrugs of such compounds, to pharmaceutical compositions comprising such compounds, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by the inhibition of NLRP3.Type: ApplicationFiled: November 9, 2018Publication date: November 12, 2020Inventors: Matthew COOPER, David MILLER, Angus MACLEOD, Stephen THOM, Jonathan SHANNON, Jokin Carrillo ARREGUI
-
Publication number: 20200329326Abstract: Methods for dialogue enhancing audio content, comprising providing a first audio signal presentation of the audio components, providing a second audio signal presentation, receiving a set of dialogue estimation parameters configured to enable estimation of dialogue components from the first audio signal presentation, applying said set of dialogue estimation parameters to said first audio signal presentation, to form a dialogue presentation of the dialogue components; and combining the dialogue presentation with said second audio signal presentation to form a dialogue enhanced audio signal presentation for reproduction on the second audio reproduction system, wherein at least one of said first and second audio signal presentation is a binaural audio signal presentation.Type: ApplicationFiled: June 29, 2020Publication date: October 15, 2020Applicants: Dolby Laboratories Licensing Corporation, Dolby International ABInventors: Leif Jonas SAMUELSSON, Dirk Jeroen BREEBAART, David Matthew COOPER, Jeroen KOPPENS
-
Publication number: 20200317637Abstract: The present invention relates to sulfonylureas and sulfonylthioureas comprising as-membered nitrogen-containing heteroaryl ring attached to the sulfonyl group, wherein the heteroaryl ring is substituted with at least one group containing an oxygen atom, and wherein said oxygen atom is attached to the heteroaryl ring via at least two other atoms. The present invention further relates to salts, solvates and prodrugs of such compounds, to pharmaceutical compositions comprising such compounds, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by the inhibition of NLRP3.Type: ApplicationFiled: November 9, 2018Publication date: October 8, 2020Inventors: Matthew COOPER, David MILLER, Angus MACLEOD, Stephen THOM, Stephen ST-GALLAY, Jonathan SHANNON, Ian STRUTT
-
Publication number: 20200299284Abstract: The present invention relates to compounds of formula (I), and pharmaceutically acceptable salts, solvates and prodrugs thereof: wherein Q is selected from O, S and Se; J is S or Se; W1 and W2, when present, are independently selected from N and C; R1 and R2 are independently selected from the group consisting of hydrogen, C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, aryl, heterocyclyl, heteroaryl, cycloalkyl, cycloalkenyl, amino, amido, alkylthio, acyl, arylalkyl and acylamido, all of which may be optionally substituted; and wherein at least one of W1 and W2 is present and is a nitrogen atom and when R1 or R2 are cyclic then the respective W1 or W2 may form part of the ring structure. The present invention also relates to pharmaceutical compositions including such compounds, to methods of treatment using such compounds, in particular in relation to NLRP3 inflammasome mediated disorders, and to associated diagnostic uses.Type: ApplicationFiled: February 16, 2017Publication date: September 24, 2020Inventors: Luke O'NEILL, Rebecca COLL, Matthew COOPER, Avril ROBERTSON, Kate SCHRODER, Angus Murray MACLEOD, David John MILLER
-
Patent number: D906806Type: GrantFiled: March 22, 2019Date of Patent: January 5, 2021Assignees: The Coca-Cola Company, Disney Enterprises, Inc.Inventors: Rohit Joshi, Matthew Cooper, Susan Propp, Ellen Gutierrez, Michael Pickholtz, Christopher Lee Beatty, Brian Scott Loo, Darin Pugne, Carl Smith